These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 21687692
41. Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity. Sallenave JM. Am J Respir Cell Mol Biol; 2010 Jun; 42(6):635-43. PubMed ID: 20395631 [Abstract] [Full Text] [Related]
42. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Rao NV, Marshall BC, Gray BH, Hoidal JR. Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709 [Abstract] [Full Text] [Related]
43. The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis. Jaovisidha K, Etim A, Yamakawa K, Masuda I, Gohr CM, Wakim BT, Boonapatcharoen N, Ninomiya J, Rosenthal AK. J Rheumatol; 2006 Feb; 33(2):318-25. PubMed ID: 16465664 [Abstract] [Full Text] [Related]
44. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis. Guyot N, Butler MW, McNally P, Weldon S, Greene CM, Levine RL, O'Neill SJ, Taggart CC, McElvaney NG. J Biol Chem; 2008 Nov 21; 283(47):32377-85. PubMed ID: 18799464 [Abstract] [Full Text] [Related]
45. Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor. Mihaila A, Tremblay GM. Z Naturforsch C J Biosci; 2001 Nov 21; 56(3-4):291-7. PubMed ID: 11371023 [Abstract] [Full Text] [Related]
46. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling. Sivaramakrishnan M, Croll TI, Gupta R, Stupar D, Van Lonkhuyzen DR, Upton Z, Shooter GK. Biochim Biophys Acta; 2013 Dec 21; 1833(12):3176-3185. PubMed ID: 24036101 [Abstract] [Full Text] [Related]
47. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells. Higashimoto Y, Yamagata Y, Iwata T, Ishiguchi T, Okada M, Masuda M, Satoh H, Itoh H. Respiration; 2005 Dec 21; 72(6):629-35. PubMed ID: 16355004 [Abstract] [Full Text] [Related]
49. Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody. Mitkevich OV, Shainoff JR, DiBello PM, Yee VC, Teller DC, Smejkal GB, Bishop PD, Kolotushkina IS, Fickenscher K, Samokhin GP. J Biol Chem; 1998 Jun 05; 273(23):14387-91. PubMed ID: 9603949 [Abstract] [Full Text] [Related]
50. Expression of serine protease inhibitors in epidermal keratinocytes is increased by calcium but not 1,25-dihydroxyvitamin D3 or retinoic acid. Kobashi M, Morizane S, Sugimoto S, Sugihara S, Iwatsuki K. Br J Dermatol; 2017 Jun 05; 176(6):1525-1532. PubMed ID: 27797397 [Abstract] [Full Text] [Related]
51. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid. Sathe S, Sakata M, Beaton AR, Sack RA. Curr Eye Res; 1998 Apr 05; 17(4):348-62. PubMed ID: 9561826 [Abstract] [Full Text] [Related]
52. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. McNeely TB, Shugars DC, Rosendahl M, Tucker C, Eisenberg SP, Wahl SM. Blood; 1997 Aug 01; 90(3):1141-9. PubMed ID: 9242546 [Abstract] [Full Text] [Related]
53. Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation. Bouloukaki I, Tsiligianni IG, Tsoumakidou M, Mitrouska I, Prokopakis EP, Mavroudi I, Siafakas NM, Tzanakis N. BMC Pulm Med; 2011 Jun 02; 11():35. PubMed ID: 21635782 [Abstract] [Full Text] [Related]
54. Secretory leukocyte protease inhibitor promising protective roles in obesity-associated atherosclerosis. Zhong QQ, Wang X, Li YF, Peng LJ, Jiang ZS. Exp Biol Med (Maywood); 2017 Feb 02; 242(3):250-257. PubMed ID: 27698252 [Abstract] [Full Text] [Related]
55. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Bergenfeldt M, Axelsson L, Ohlsson K. Scand J Clin Lab Invest; 1992 Dec 02; 52(8):823-9. PubMed ID: 1362620 [Abstract] [Full Text] [Related]
56. Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA. Hoffmann BR, Annis DS, Mosher DF. J Biol Chem; 2011 Sep 16; 286(37):32220-30. PubMed ID: 21757696 [Abstract] [Full Text] [Related]
57. Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase. Hang J, Zemskov EA, Lorand L, Belkin AM. J Biol Chem; 2005 Jun 24; 280(25):23675-83. PubMed ID: 15849356 [Abstract] [Full Text] [Related]
58. Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures. Cui C, Wang S, Myneni VD, Hitomi K, Kaartinen MT. Bone; 2014 Feb 24; 59():127-38. PubMed ID: 24246248 [Abstract] [Full Text] [Related]
59. Accumulation of elafin in actinic elastosis of sun-damaged skin: elafin binds to elastin and prevents elastolytic degradation. Muto J, Kuroda K, Wachi H, Hirose S, Tajima S. J Invest Dermatol; 2007 Jun 24; 127(6):1358-66. PubMed ID: 17139263 [Abstract] [Full Text] [Related]
60. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung. Tremblay GM, Sallenave JM, Israél-Assayag E, Cormier Y, Gauldie J. Am J Respir Crit Care Med; 1996 Oct 24; 154(4 Pt 1):1092-8. PubMed ID: 8887613 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]